Clients hold the 1.85M Charles River (CRL) shares underlying Invesco’s reported 3.9% stake.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Invesco Ltd. has reported a beneficial ownership of 1,852,539 shares of Charles River Laboratories International, Inc. (CRL), representing 3.9% of the common stock. These shares are held by Invesco clients, who retain the economic rights, including dividends and sale proceeds. Invesco itself maintains sole voting power over 1,845,388 shares and sole dispositive power over all 1,852,539 shares.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.